View in EDS HTML Full Text PDF Full Text

A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey.

Saved in:
Bibliographic Details
Title: A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey.
Authors: Wang XH; Gansu Provincial Cancer Hospital, Lanzhou, China., Wang ZZ; School of Public Health, Gansu University of Chinese Medicine, Lanzhou, China., Xu HF; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China., Liu HW; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China., Wang DL; School of Public Health, Gansu University of Chinese Medicine, Lanzhou, China., Feng CY; Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China., Zhang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing, China., Wang WJ; School of Nursing, Jining Medical University, Jining, China., Yu YQ; The Department of Public Health and Preventive Medicine, The Research Center of Clinical epidemiology, Baotou Medical College, Baotou, Inner Mongolia, China., Duan SX; Xinxiang Central Hospital, Xinxiang, China., Shi JH; The Department of Public Health and Preventive Medicine, The Research Center of Clinical epidemiology, Baotou Medical College, Baotou, Inner Mongolia, China., Zhao YQ; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China., Li M; Public Health School, Dalian Medical University, Dalian, China., Liu YY; Liaoning Office for Cancer Control and Research, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China., Huang JX; Wuzhou Red Cross Hospital, Wuzhou, China., Fan YP; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Cao J; The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China., Gu XF; Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi, Xinjiang, China., Li L; Department of Clinical Research, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China., Lian XM; School of Public Health and Management, Chongqing Medical University, Chongqing, China., Du JC; College of Public Health, Chengdu Medical College, Chengdu, China., Qiao YL; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
Source: Frontiers in oncology [Front Oncol] 2026 May 14; Vol. 16, pp. 1646284. Date of Electronic Publication: 2026 May 14 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42222417
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+XH%22">Wang XH</searchLink>; Gansu Provincial Cancer Hospital, Lanzhou, China.<br /><searchLink fieldCode="AU" term="%22Wang+ZZ%22">Wang ZZ</searchLink>; School of Public Health, Gansu University of Chinese Medicine, Lanzhou, China.<br /><searchLink fieldCode="AU" term="%22Xu+HF%22">Xu HF</searchLink>; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Liu+HW%22">Liu HW</searchLink>; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Wang+DL%22">Wang DL</searchLink>; School of Public Health, Gansu University of Chinese Medicine, Lanzhou, China.<br /><searchLink fieldCode="AU" term="%22Feng+CY%22">Feng CY</searchLink>; Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Wang+WJ%22">Wang WJ</searchLink>; School of Nursing, Jining Medical University, Jining, China.<br /><searchLink fieldCode="AU" term="%22Yu+YQ%22">Yu YQ</searchLink>; The Department of Public Health and Preventive Medicine, The Research Center of Clinical epidemiology, Baotou Medical College, Baotou, Inner Mongolia, China.<br /><searchLink fieldCode="AU" term="%22Duan+SX%22">Duan SX</searchLink>; Xinxiang Central Hospital, Xinxiang, China.<br /><searchLink fieldCode="AU" term="%22Shi+JH%22">Shi JH</searchLink>; The Department of Public Health and Preventive Medicine, The Research Center of Clinical epidemiology, Baotou Medical College, Baotou, Inner Mongolia, China.<br /><searchLink fieldCode="AU" term="%22Zhao+YQ%22">Zhao YQ</searchLink>; Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Public Health School, Dalian Medical University, Dalian, China.<br /><searchLink fieldCode="AU" term="%22Liu+YY%22">Liu YY</searchLink>; Liaoning Office for Cancer Control and Research, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China.<br /><searchLink fieldCode="AU" term="%22Huang+JX%22">Huang JX</searchLink>; Wuzhou Red Cross Hospital, Wuzhou, China.<br /><searchLink fieldCode="AU" term="%22Fan+YP%22">Fan YP</searchLink>; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Cao+J%22">Cao J</searchLink>; The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.<br /><searchLink fieldCode="AU" term="%22Gu+XF%22">Gu XF</searchLink>; Affiliated Tumor Hospital, Xinjiang Medical University, Urumqi, Xinjiang, China.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Department of Clinical Research, The First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, China.<br /><searchLink fieldCode="AU" term="%22Lian+XM%22">Lian XM</searchLink>; School of Public Health and Management, Chongqing Medical University, Chongqing, China.<br /><searchLink fieldCode="AU" term="%22Du+JC%22">Du JC</searchLink>; College of Public Health, Chengdu Medical College, Chengdu, China.<br /><searchLink fieldCode="AU" term="%22Qiao+YL%22">Qiao YL</searchLink>; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 May 14; Vol. 16, pp. 1646284. <i>Date of Electronic Publication: </i>2026 May 14 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42222417
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2026.1646284
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1646284
    Titles:
      – TitleFull: A study of factors influencing access to MDT among patients with stage III to stage IV colorectal cancer: a national multicenter survey.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang XH
      – PersonEntity:
          Name:
            NameFull: Wang ZZ
      – PersonEntity:
          Name:
            NameFull: Xu HF
      – PersonEntity:
          Name:
            NameFull: Liu HW
      – PersonEntity:
          Name:
            NameFull: Wang DL
      – PersonEntity:
          Name:
            NameFull: Feng CY
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Wang WJ
      – PersonEntity:
          Name:
            NameFull: Yu YQ
      – PersonEntity:
          Name:
            NameFull: Duan SX
      – PersonEntity:
          Name:
            NameFull: Shi JH
      – PersonEntity:
          Name:
            NameFull: Zhao YQ
      – PersonEntity:
          Name:
            NameFull: Li M
      – PersonEntity:
          Name:
            NameFull: Liu YY
      – PersonEntity:
          Name:
            NameFull: Huang JX
      – PersonEntity:
          Name:
            NameFull: Fan YP
      – PersonEntity:
          Name:
            NameFull: Cao J
      – PersonEntity:
          Name:
            NameFull: Gu XF
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Lian XM
      – PersonEntity:
          Name:
            NameFull: Du JC
      – PersonEntity:
          Name:
            NameFull: Qiao YL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 05
              Text: 2026 May 14
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1